Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20589530rdf:typepubmed:Citationlld:pubmed
pubmed-article:20589530lifeskim:mentionsumls-concept:C0023690lld:lifeskim
pubmed-article:20589530lifeskim:mentionsumls-concept:C0206190lld:lifeskim
pubmed-article:20589530lifeskim:mentionsumls-concept:C1819439lld:lifeskim
pubmed-article:20589530lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:20589530lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:20589530lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:20589530pubmed:issue5lld:pubmed
pubmed-article:20589530pubmed:dateCreated2010-8-4lld:pubmed
pubmed-article:20589530pubmed:abstractTextWe have previously shown that murine resident peritoneal macrophages (PEMs) are activated in response to uptake of oligomannose-coated liposomes (OMLs), leading to production of interleukin (IL)-12. To understand the mechanism of activation of PEMs by OMLs, in the present study we investigated the role of a mannose-binding C-type lectin receptor, SIGNR1, in production of proinflammatory cytokines by PEMs, in which SIGNR1 acts as a physiological receptor for OMLs. Engagement of SIGNR1 on PEMs with an anti-SIGNR1-specific rat IgM antibody, ERTR9, induced production of IL-12 and tumor necrosis factor (TNF)-alpha from PEMs, while secretion of IL-6 and IL-1beta was not detected with the same treatment. The level of phosphorylated IkappaB kinase in PEMs also increased in response to ERTR9 treatment of the cells. Treatment of PEMs with a specific nuclear factor kappa-B (NFkappaB) inhibitor, BAY11-7082, reduced ERTR9-dependent IL-12 production. Intraperitoneal treatment with BAY11-7082 also led to reduction of subsequent OML-induced IL-12 production from PEMs. These results indicate that SIGNR1-mediated intercellular signaling may induce production of cytokines such as IL-12 through NFkappaB activation.lld:pubmed
pubmed-article:20589530pubmed:languageenglld:pubmed
pubmed-article:20589530pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20589530pubmed:citationSubsetIMlld:pubmed
pubmed-article:20589530pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20589530pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20589530pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20589530pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20589530pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20589530pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20589530pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20589530pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20589530pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20589530pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20589530pubmed:statusMEDLINElld:pubmed
pubmed-article:20589530pubmed:monthJullld:pubmed
pubmed-article:20589530pubmed:issn1573-4986lld:pubmed
pubmed-article:20589530pubmed:authorpubmed-author:KojimaNaoyaNlld:pubmed
pubmed-article:20589530pubmed:authorpubmed-author:KatoChiakiClld:pubmed
pubmed-article:20589530pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20589530pubmed:volume27lld:pubmed
pubmed-article:20589530pubmed:ownerNLMlld:pubmed
pubmed-article:20589530pubmed:authorsCompleteYlld:pubmed
pubmed-article:20589530pubmed:pagination525-31lld:pubmed
pubmed-article:20589530pubmed:meshHeadingpubmed-meshheading:20589530...lld:pubmed
pubmed-article:20589530pubmed:meshHeadingpubmed-meshheading:20589530...lld:pubmed
pubmed-article:20589530pubmed:meshHeadingpubmed-meshheading:20589530...lld:pubmed
pubmed-article:20589530pubmed:meshHeadingpubmed-meshheading:20589530...lld:pubmed
pubmed-article:20589530pubmed:meshHeadingpubmed-meshheading:20589530...lld:pubmed
pubmed-article:20589530pubmed:meshHeadingpubmed-meshheading:20589530...lld:pubmed
pubmed-article:20589530pubmed:meshHeadingpubmed-meshheading:20589530...lld:pubmed
pubmed-article:20589530pubmed:meshHeadingpubmed-meshheading:20589530...lld:pubmed
pubmed-article:20589530pubmed:meshHeadingpubmed-meshheading:20589530...lld:pubmed
pubmed-article:20589530pubmed:meshHeadingpubmed-meshheading:20589530...lld:pubmed
pubmed-article:20589530pubmed:meshHeadingpubmed-meshheading:20589530...lld:pubmed
pubmed-article:20589530pubmed:meshHeadingpubmed-meshheading:20589530...lld:pubmed
pubmed-article:20589530pubmed:meshHeadingpubmed-meshheading:20589530...lld:pubmed
pubmed-article:20589530pubmed:year2010lld:pubmed
pubmed-article:20589530pubmed:articleTitleSIGNR1 ligation on murine peritoneal macrophages induces IL-12 production through NFkappaB activation.lld:pubmed
pubmed-article:20589530pubmed:affiliationInstitute of Glycoscience, Tokai University, Hiratsuka, Kanagawa, 259-1292, Japan.lld:pubmed
pubmed-article:20589530pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20589530pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed